| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |